CEO Chris Gibson highlighted significant progress in 2024, including clinical data readouts from REC-617 and REC-994, which showed early efficacy signals and robust safety, respectively. REC-617, a ...

Additionally, Recursion plans to present updated clinical data from the TUPELO trial during a webinar scheduled for December 8, 2025. This presentation will provide further insights into the safety ...

Hundreds of people gathered at the Alton Baker Park in Eugene on Saturday to participate in The People's March, the local ...

It’s been three years since OpenAI released ChatGPT and kicked off a surge in innovation and attention on AI. Since then, optimists have regularly claimed that AI will become a critical part of the ...